Scope of the Report:The global Rapid Influenza Diagnostic Test (RIDT) market is valued at 1001.3 million USD in 2020 and is expected to reach 1377.3 million USD by the end of 2026, growing at a CAGR of 8.3% between 2020 and 2026.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Rapid Influenza Diagnostic Test (RIDT).
Europe also play important roles in global market, with market size of xx million USD in 2020 and will be xx million USD in 2026, with a CAGR of xx%.
This report studies the Rapid Influenza Diagnostic Test (RIDT) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Rapid Influenza Diagnostic Test (RIDT) market by product type and applications/end industries.
Market Segment by Companies, this report covers Analytik Jena
Princeton BioMeditech Corporation
Roche
Abbot (Alere)
BD
Quidel
Sekisui Diagnostics
Meridian Bioscience
Thermo Fisher Scientific
BioMerieux
Response Biomedical
SA Scientific
DiaSorin (Focus Diagnostics)
Market Segment by Regions, regional analysis coversNorth America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers Digital RIDTs
Conventional RIDT
in 2019, Digital RIDTs accounted for a major share of 55.36% the global Rapid Influenza Diagnostic Test (RIDT) market. And this product segment is poised to reach 1039.09 million US$ by 2026 from 588.84 million US$ in 2019.
Market Segment by Applications, can be divided into Hospitals
POCT
Others
In Rapid Influenza Diagnostic Test (RIDT) market, the Hospitals holds an important share in terms of application, and it is expected to reach revenue of by 2026, at a CAGR of 8.37% during 2020 and 2026.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
